Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Download Lucid FlowChart to plan processes, map decisions, and present polished diagrams in minutes. Built for teams and individuals, this flowchart maker helps turn complex ideas into clear visuals ...

Google announced major upgrades to its AI-powered creative platform Google Flow at Google I/O 2026, introducing new tools aimed at filmmakers, video creators, and musicians. The biggest addition is ...

Google Flow Music is an AI-based platform that enables users to create and customize music through simple text prompts. Teacher’s Tech explains how to access the platform via flowmusic.app and ...

“Celebrate Me,” a TikTok-viral song that was created with the AI music generator Suno, is No. 1 on the iTunes chart in the United States and several other countries as the AI music generator grows in ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Lucid Motor said it expects to be cash flow positive late this decade. The company held its first investor day in nearly five years as a public company. The EV company is aiming to hit that target ...

It was almost a year ago when Toyota Motor North America first made our acquaintance with the newest exclusive color – and it was something that would definitely make waves across all TRD Pro models ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...